Background and Goal of Study:: High bleeding and transfusion risk is very common in certain orthopaedic procedures. Cell saver significantly forms part in a blood saving strategy. The aim of the study was to analyse the impact of cell saver and its effect on transfusion rate and to compare it with its avoidance on high risk bleeding orthopaedic procedures (HRBOP).
Materials and Methods: Observational prospective study analysing recorded data of HRBOP patients in the period 2011-2014: Demographic data, procedure, preoperative and postoperative haemoglobin, perioperative bleeding, and cell saver use, autologous and alogenic transfusion rates.
Results and Discussion:In the 2011-2014 period 72 HRBOP patients were identified. We found 57 cases eligible for cell saver. Finally, cell saver and autologous blood transfusion (ABT) was adopted in 19 cases (33%). Age (average standard deviation) 73,6 7,4;Females 59,6%. Femur Peri-prosthetic fractures 22% Primary hip prosthesis 18% rescue hip prosthesis 60%. Preoperative haemoglobin was 12,3 2,6 gr/dl; 31%
of the patients were anaemic before surgery; perioperative bleeding was 1683 +-697 ml. Alogenic blood transfusion (ABT) was needed in 61,4% of the patients (57,9% (cell saver) vs. 63,2% (no cell saver). Non-Anaemic patients without cell saver implementation were transfused 61% in contrast to the cell saver group that were transfused 50% of times. Paradoxically, Anaemic patients with cell saver utilisation were transfused 100% and 67% when it was not implemented.
Conclusion(s): Bleeding and transfusion rates in HRBOP are high. A significant number of patients come
anaemic to surgery. Cell saver implementation can reduce HTB in certain grup of patients

06 / Efficacy of cell saver on high bleeding risk orthopaedic patients. A retrospective comparative study